GU Cancers 2020 | Individualizing RCC treatment

VJOncology is committed to improving our service to you

Martin Voss

Martin Voss, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses updates on the progression towards individualizing therapy for metastatic renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter